Vakona
PrivateLast Round
VC Round
Apr 28, 2025
Total Funding Raised
$1.73M
Company Overview
Vakona operates in Healthcare & Life Sciences and is based in Umeå. Its latest recorded funding round was a VC Round in April 2025.
Vakona is a pharmaceutical company developing a novel, antibiotic-free treatment for acne vulgaris by targeting bacterial biofilms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vakona Comparables
Compare Vakona with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Derm-Biome Pharmaceuticals | 79% | |
| AOBiome Therapeutics Inc. | 73% | |
| Dermata Therapeutics, Inc. | 71% |
For institutional investors. Book with your work email.
Vakona Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 28, 2025 | ||||
| VC Round | Mar 29, 2023 | ||||
| Seed | Nov 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vakona Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phase2Phase Biopharma | Seed, VC Round |
| Stockholm Business Angels | Seed, VC Round |
| Partnerinvest Norr | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 29, 2023
$1.33M round from Partnerinvest Norr and others.
For institutional investors. Book with your work email.
Vakona Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vakona's valuation, stock price, and market status.
Is Vakona a public or private company?
Vakona is a private company.
What is the current stock price of Vakona?
Vakona is a private company, so its shares have no public market price. Caplight tracks Vakona's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vakona worth (valuation)?
Valuation information for Vakona is not publicly available.
Can I buy Vakona stock?
Vakona shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vakona's last funding round?
Vakona's most recent funding round was VC Round on April 28, 2025.
Who are the main investors in Vakona?
Key investors in Vakona include Phase2Phase Biopharma, Stockholm Business Angels, Partnerinvest Norr.
Will Vakona IPO soon?
No public IPO plans have been announced for Vakona.
How can I track Vakona secondary market activity?
Caplight tracks bids, offers, and trades in Vakona's shares on secondary markets.